Barclays
VERA icon

Barclays’s Vera Therapeutics VERA Stock Holding History

Barclays’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.66M Sell
225,118
-7,398
-3% -$276K ﹤0.01% 1495
2026
Q1 		$9.35M Sell
232,516
-21,200
-8% -$913K ﹤0.01% 1486
2025
Q4 		$12.8M Buy
253,716
+36,123
+17% +$1.28M ﹤0.01% 1505
2025
Q3 		$6.32M Buy
217,593
+6,716
+3% +$155K ﹤0.01% 2014
2025
Q2 		$4.97M Buy
210,877
+121,161
+135% +$2.72M ﹤0.01% 2143
2025
Q1 		$2.15M Sell
89,716
-9,432
-10% -$303K ﹤0.01% 2574
2024
Q4 		$4.19M Buy
99,148
+13,753
+16% +$609K ﹤0.01% 2320
2024
Q3 		$3.77M Buy
85,395
+41,394
+94% +$1.57M ﹤0.01% 2320
2024
Q2 		$1.59M Buy
44,001
+433
+1% +$17.2K ﹤0.01% 2298
2024
Q1 		$1.88M Sell
43,568
-70,179
-62% -$2.5M ﹤0.01% 2622
2023
Q4 		$1.75M Buy
113,747
+42,044
+59% +$534K ﹤0.01% 3026
2023
Q3 		$983K Buy
71,703
+64,968
+965% +$1.11M ﹤0.01% 2351
2023
Q2 		$108K Sell
6,735
-4,237
-39% -$38.3K ﹤0.01% 3524
2023
Q1 		$85.1K Sell
10,972
-2,307
-17% -$17.8K ﹤0.01% 4266
2022
Q4 		$257K Buy
13,279
+3,254
+32% +$58.9K ﹤0.01% 3709
2022
Q3 		$214K Buy
10,025
+9,329
+1,340% +$175K ﹤0.01% 3158
2022
Q2 		$9K Sell
696
-1,526
-69% -$26.6K ﹤0.01% 4669
2022
Q1 		$53K Buy
+2,222
New +$47.8K ﹤0.01% 4101

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barclays's VERA Position: Q2 2026 in Review

Barclays reduced its Vera Therapeutics (VERA) stake by 3.2% in Q2 2026, selling an estimated $276K and leaving 225,118 shares worth $9.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1495.

Barclays first reported a position in VERA in Q1 2022 and has held it in 18 quarters since. The position peaked at $12.8M in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Barclays held 225,118 shares of Vera Therapeutics worth $9.66M as of Q2 2026.
  • Barclays sold 7,398 Vera Therapeutics shares in Q2 2026, an estimated $276K.
  • Vera Therapeutics made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1495 holding.
  • Barclays first reported a position in Vera Therapeutics in Q1 2022 and has held it in 18 quarters since.
  • Barclays's Vera Therapeutics position peaked at $12.8M in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.